Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
75 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)
Overview
This study is a comprehensive report on the Molecular Diagnostics market, with particular focus on industry outlook, growth drivers, market segmentation, competitive scenario and critical success factors. This research report provides statistical data, including market size by product and application for historic years of 2012 and 2013, with forecast up to 2020.
The report firstly provides market segmentation, current market scenario, growth prospects and value chain analysis. Then the report analyzes the Asia Pacific Molecular Diagnostics market dynamics in-depth which include growth feasibility analysis, market driver impact analysis, five force analysis, and PESTEL analysis. The growth feasibility analysis points out key areas in this industry that represent high growth opportunities for market players over the forecast period.
Additionally, this report includes comprehensive industry landscape, with market dynamics, drivers, restraints, and opportunities. This report will help you discover the latest market trends and reveal sources of future market growth for Asia Pacific Molecular Diagnostics market. If you are looking for a detailed report on Molecular Diagnostics market, our research will save you time and effort while empowering you to make informed decisions.
This research report on Molecular Diagnostics market includes: Market estimate and forecast of Molecular Diagnostics market Key factors driving the growth of Molecular Diagnostics market Detailed profile of the key players operating in this market Five year forecasts of market trends and market growth Challenges and opportunities in Molecular Diagnostics market Why buy this report? Molecular Diagnostics market size, growth rate and forecast to 2020 Track key market trends, opportunities and threats Make informed decisions related to marketing, branding, strategy building, and market development Competitive landscape with company market share and detailed profiles of key market players
Table of Contents
Chapter 1. Executive Summary 1.1. Molecular Diagnostics - Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Molecular Diagnostics Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 3. Molecular Diagnostics Market Dynamics 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Molecular Diagnostics - Company Market Share Analysis 2.7. Molecular Diagnostics Market PESTEL Analysis, 2012
Chapter 3. Molecular Diagnostics Product Outlook 3.1. Instruments 3.2. Reagents 3.3. Others
Chapter 4. Molecular Diagnostics Technology Outlook 4.1. PCR 4.2. In Situ Hybridization 4.3. Chips and Microarrays 4.4. Mass Spectrometry 4.5. Sequencing 4.6. Others
Chapter 5. Molecular Diagnostics Application Outlook 5.1. Oncology 5.2. Pharmacogenomics 5.3. Infectious Disease 5.4. Genetic Testing 5.5. Neurological Disease 5.6. Cardiovascular Disease 5.7. Others
Chapter 6. Molecular Diagnostics End-User Outlook 6.1. Point of Care 6.2. Self Test or OTC 6.3. Central Laboratories
Chapter 7 Competitive landscape 7.1 Roche Diagnostics 7.1.1 Company Overview 7.1.2 Financial Performance 7.1.3 Product Benchmarking 7.1.4 Strategic Initiatives 7.2 Abbott Laboratories 7.2.1 Company Overview 7.2.2 Financial Performance 7.2.3 Product Benchmarking 7.2.4 Strategic Initiatives 7.3 Siemens Healthcare 7.3.1 Company Overview 7.3.2 Financial Performance 7.3.3 Product Benchmarking 7.3.4 Strategic Initiatives 7.4 Johnson and Johnson 7.4.1 Company Overview 7.4.2 Financial Performance 7.4.3 Product Benchmarking 7.4.4 Strategic Initiatives 7.5 Bio-Rad Laboratories 7.5.1 Company Overview 7.5.2 Financial Performance 7.5.3 Product Benchmarking 7.5.4 Strategic Initiatives 7.6 Beckman Coulter Inc. 7.6.1 Company Overview 7.6.2 Financial Performance 7.6.3 Product Benchmarking 7.6.4 Strategic Initiatives 7.7 Becton Dickinson 7.7.1 Company Overview 7.7.2 Financial Performance 7.7.3 Product Benchmarking 7.7.4 Strategic Initiatives 7.8 bioMerieux 7.8.1 Company Overview 7.8.2 Financial Performance 7.8.3 Product Benchmarking 7.8.4 Strategic Initiatives 7.9 Sysmex 7.9.1 Company Overview 7.9.2 Financial Performance 7.9.3 Product Benchmarking 7.9.4 Strategic Initiatives 7.10 Bayer Healthcare 7.10.1 Company Overview 7.10.2 Financial Performance 7.10.3 Product Benchmarking 7.10.4 Strategic Initiatives 7.11 Alere Inc. 7.11.1 Company Overview 7.11.2 Financial Performance 7.11.3 Product Benchmarking 7.11.4 Strategic Initiatives 7.12 Danaher Corporation 7.12.1 Company Overview 7.12.2 Financial Performance 7.12.3 Product Benchmarking 7.12.4 Strategic Initiatives 7.13 Gen-Probe 7.13.1 Company Overview 7.13.2 Financial Performance 7.13.3 Product Benchmarking 7.13.4 Strategic Initiatives 7.14 Novartis 7.14.1 Company Overview 7.14.2 Financial Performance 7.14.3 Product Benchmarking 7.14.4 Strategic Initiatives 7.15 Cepheid 7.15.1 Company Overview 7.15.2 Financial Performance 7.15.3 Product Benchmarking 7.15.4 Strategic Initiatives 7.16 Qiagen 7.16.1 Company Overview 7.16.2 Financial Performance 7.16.3 Product Benchmarking 7.16.4 Strategic Initiatives 7.17 Leica Biosystems 7.17.1 Company Overview 7.17.2 Financial Performance 7.17.3 Product Benchmarking 7.17.4 Strategic Initiatives 7.18 Dako 7.18.1 Company Overview 7.18.2 Financial Performance 7.18.3 Product Benchmarking 7.18.4 Strategic Initiatives
Chapter 8. Methodology and Scope 8.1. Research Methodology 8.2. Research Scope & Assumption 8.3. List of Data Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
